Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00227_DB00625> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00227_DB00625 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00227_DB00625 label "DDI between Lovastatin and Efavirenz - Efavirenz may decrease the serum concentration of lovastatin by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of lovastatin if efavirenz is initiated, discontinued or dose changed. [drugbank_resource:DB00227_DB00625]" assertion.
- drugbank_resource:DB00227_DB00625 identifier "drugbank_resource:DB00227_DB00625" assertion.
- drugbank_resource:DB00227_DB00625 title "DDI between Lovastatin and Efavirenz - Efavirenz may decrease the serum concentration of lovastatin by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of lovastatin if efavirenz is initiated, discontinued or dose changed." assertion.